Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1362 of 5804
-
New Tooth-Saving material could spare kids from extractions
Disease control CompletedWhen a permanent back tooth develops severe nerve inflammation that cannot heal on its own, a procedure called pulpotomy can be performed to remove the diseased nerve tissue from the crown of the tooth while preserving the healthy roots. This helps save the tooth and avoid extrac…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Dates and moringa show promise for postpartum depression and breast milk
Symptom relief CompletedPostpartum depression affects 10-20% of new mothers globally, potentially disrupting breast milk production. This study aimed to provide valuable insights into effective interventions to improve the health and well-being of Postpartum Mothers with depression. This study used a ra…
Phase: NA • Sponsor: Melania Asi • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Pre-Surgery breathing workouts may boost heart transplant recovery
Symptom relief Recruiting nowThis research study is investigating whether completing breathing exercises before surgery helps heart transplant patients recover after surgery. Previous studies have shown that breathing exercises can improve breathing, cough, and swallow function in patients with other disease…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New diabetes drug HRS-7535 shows promise in early trial
Disease control Completed2 weeks screening period, 3 weeks run-in period, 16 weeks double-blind treatment period, to evaluate the Safety and Efficacy of HRS-7535 in Subjects with Type 2 Diabetes who have Inadequate Glycemic Control on Metformin and SGLT2i.
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New pill aims to ease muscle weakness in rare nerve disease
Disease control Recruiting nowThis Phase 2 proof-of-concept, dose range finding study aims to evaluate the safety and efficacy of 3 dose levels of NMD670 vs placebo in adult patients with MG with antibodies against AChR or MuSK, administered twice a day (BID) for 21 days.
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
FDA-Approved drug shows promise for Tough-to-Treat EoE with strictures
Disease control OngoingThe purpose of this research study is to determine how well an FDA-approved drug, dupilumab, works to treat patients with severe strictures and active Eosinophilic Esophagitis (EoE). This is an open-label study, meaning everyone in the study will receive dupilumab. Participants …
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Scientists reprogram immune cells to attack common cancer mutation
Disease control OngoingBackground: Many cancer cells produce substances called antigens that are unique to each cancer. These antigens stimulate the body s immune responses. One approach to treating these cancers is to take disease-fighting white blood cells from a person, change those cells so they w…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New app aims to protect native women from alcohol-affected pregnancies
Prevention CompletedThe purpose of Aim 1 of the study is to gather quantitative and qualitative information to inform the development of a digital app tailored for Native American women to help them avoid a pregnancy affected by alcohol. In Aim 2, we will Pilot test 5 new candidate components tailor…
Phase: NA • Sponsor: University of Virginia • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Laser zaps spine tumors without open surgery – new study launches
Disease control Recruiting nowThe objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniq…
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Mobile clinics and Drop-In care aim to reach HIV patients falling through the cracks
Disease control Recruiting nowThe purpose of this study is to evaluate the implementation and effectiveness of a flexible, multidisciplinary, integrated drop-in/mobile HIV care approach for people living with HIV (PLH) who are not well engaged in current care systems (i.e. scheduled HIV primary care visits). …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Blood test may spare thousands from unnecessary brain scans
Diagnosis CompletedDecision Rules for an initial CT-scan in patients arriving to Emergency Department (ED) and presenting a mild traumatic brain injury could be optimized by the use of an objective parameter easily and rapidly measured. This may be the place for serum biomarkers providing a quick a…
Phase: NA • Sponsor: BioMérieux • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New heart valve aims for better Long-Term results
Disease control Recruiting nowThe issue of valve durability has become one of the most important aspects in the TAVR field in recent years since transcatheter aortic valve replacement has been progressively applied to younger patients with a low co-morbidity burden. The SAPIEN 3 Ultra RESILIA valve represents…
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Weekly pill could slow aging: early trial launches
Disease control Recruiting nowThe objective of RAP PAC is to identify safe and effective weekly dose(s) for the mTOR inhibitors sirolimus and everolimus that intervene on the underlying fundamental biology of aging. Participants who are 55-89 years old that are free of overt chronic diseases will be assigned …
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could fewer zaps do the job? new trial tests low-dose radiation for lymphoma
Disease control Recruiting nowThis phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patients with indolent non-Hodgkin lymphoma. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New antibody aims to reverse cancer wasting
Symptom relief Recruiting nowA Phase Ia/II, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of JMT203 in Patients with Cancer Cachexia
Phase: PHASE1, PHASE2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Magnetic pulses to the brain could lift bipolar depression
Symptom relief Recruiting nowThe purpose of this trial is to determine if intermittent theta-burst stimulation (iTBS) can reduce the symptoms of depression in treatment-resistant bipolar disorder. To do this, some of the participants in this study will receive treatment with active iTBS stimulation, while ot…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Could dupixent help kids with chronic itchy skin disease?
Disease control Recruiting nowThis is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study. The study consists of 3 periods: * Screening period: 2 to 4 weeks. * Treatment period: 24 weeks. * Post-intervention follow-up period: 16 weeks. The study duration will be approximately 42 to 44 wee…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Botox plus mirror therapy shows promise for stroke arm stiffness
Symptom relief CompletedStroke is one of the leading causes of disability worldwide, particularly affecting the upper extremities and thus negatively impacting patients' activities of daily living and quality of life. Upper extremity spasticity, characterized by increased muscle tone and tendon reflexes…
Phase: NA • Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New hope for brain cancer? experimental drug tested in 42 patients
Disease control OngoingThis study will investigate different doses of \[177Lu\]Lu-NeoB in combination with RT and TMZ in participants with newly diagnosed glioblastoma, with methylated or unmethylated promoter, to assess the safety and efficacy of \[177Lu\]Lu-NeoB in combination with the SoC and in rec…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could chemo before surgery beat cancer better?
Disease control OngoingThis is a single-center, open-label, non-randomized controlled trial comparing the efficacy and safety of neoadjuvant chemotherapy (NAC) followed by radical surgery versus upfront radical surgery alone in patients with high-risk, non-metastatic upper tract urothelial carcinoma (U…
Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:21 UTC